|
CN111057130A
|
|
High-purity micafungin or salt thereof, and preparation method and application thereof
|
|
CN111378013A
|
|
Preparation method of high-purity cyclic peptide compound
|
|
CN107129474A
|
|
Aminosugars compound, and its production and use
|
|
CN112110991A
|
|
Composition containing nitrogen heterocyclic hexapeptide precursor and preparation method and application thereof
|
|
CN106467465A
|
|
A kind of high-purity Latanoprost and its production and use
|
|
EP3150623A1
|
|
Solvate of cyclic peptide compound, preparation method for same, and uses thereof
|
|
WO2015180681A1
|
|
Composition of cyclic peptide compound, preparation method for same, and uses thereof
|
|
US2017198013A1
|
|
Crystal of cyclic peptide compound, preparation method for same and uses thereof
|
|
CN105777869A
|
|
Cyclopeptide-type compound composition
|
|
CN105399638A
|
|
Amino sugar intermediate preparation method
|
|
CN104788545A
|
|
Crystal powder of cyclopeptide compound, and preparation method and application thereof
|
|
CN104561235A
|
|
Sterile detection method
|
|
CN104101656A
|
|
Purity determination method for gonadotropin
|
|
CN103509044A
|
|
Beraprost sodium intermediates and preparation method thereof
|
|
CN103387975A
|
|
Immobilized cyclic lipopeptide acyltransferase, preparation method thereof, and application thereof
|
|
CN102627688A
|
|
High purity cyclic peptide compound and preparation method and application thereof
|
|
CN102659930A
|
|
High-purity cyclopeptide crystal and its preparation method and use
|
|
CN102627689A
|
|
Hydrate of cyclopeptide compound as well as preparation method and application thereof
|
|
CN103193627A
|
|
Crystal form, preparation method and application of prostaglandin analogue
|
|
CN103193626A
|
|
Crystal form, preparation method and application of prostaglandin analogue
|
